Entocort EC, a new ORAL form of budesonide for Crohn's disease

AstraZeneca will soon introduce Entocort EC, a new ORAL form of budesonide for Crohn's disease.

It's approved for acute flare-ups that involve the ileum and/or ascending colon...it's not approved for chronic use.

Entocort EC releases budesonide in the small intestine and colon to decrease inflammation.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote